Computational Drug Design For Rare And Neglected Diseases: A Systematic Review of Unused Opportunities
Computer-Aided Drug Design (CADD), which bridges the fields of biology and technology, is a revolutionary force in the ever-changing field of drug development. The historical development of CADD, its classification into structure-based and ligand-based techniques, and its critical function in streamlining and accelerating drug discovery are all covered in this study. The process of designing and developing new drugs is expensive and time-consuming. These days, computer-aided drug design techniques are typically employed to increase the effectiveness of medication discovery and advancement. Computer-Aided Drug Design (CADD) is a broad field that incorporates both basic and applied analysis in many forms. It is being used in a number of disciplines, such as nanotechnology, molecular biology, and biochemistry. The pharmaceutical business and research frequently use computational tools to increase the efficacy of medication discovery and development.
Authors
- P. Sathya Sowmya
- Patlolla Ruchitha
- S. Sekar (ORCID: https://orcid.org/0009-0006-8687-8851)
- Puttagunta Varshini
- Preeti Satish
- P Ashwini
Institutions
- G Pulla Reddy Dental College & Hospital (IN)
Publication Details
- Journal
- International Journal of Research in Pharmacology & Pharmacotherapeutics
- Published
- 2025-06-24
- DOI
- https://doi.org/10.61096/ijrpp.v14.iss2.2025.463-472
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00